Oncoclínicas do Brasil Serviços Médicos S.A.

BOVESPA:ONCO3 Stock Report

Market Cap: R$1.6b

Oncoclínicas do Brasil Serviços Médicos Future Growth

Future criteria checks 4/6

Oncoclínicas do Brasil Serviços Médicos is forecast to grow earnings and revenue by 47.2% and 11.7% per annum respectively. EPS is expected to grow by 47.3% per annum. Return on equity is forecast to be 9.1% in 3 years.

Key information

47.2%

Earnings growth rate

47.3%

EPS growth rate

Healthcare earnings growth26.6%
Revenue growth rate11.7%
Future return on equity9.1%
Analyst coverage

Good

Last updated18 Dec 2024

Recent future growth updates

Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Nov 17
Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Recent updates

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Stocks Pounded By 29% But Not Lagging Market On Growth Or Pricing

Nov 23
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Stocks Pounded By 29% But Not Lagging Market On Growth Or Pricing

Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit

Nov 20
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit

Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Nov 17
Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Sep 27
With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For

Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Aug 15
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Aug 13
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt

Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Jul 16
Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%

Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Jul 03
Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?

Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Jun 01
Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%

Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Apr 17
Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Apr 03
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem

Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

Mar 11
Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet

What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

Feb 17
What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?

It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Dec 08
It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)

Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Nov 06
Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching

Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Sep 11
Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?

Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Apr 03
Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price

Earnings and Revenue Growth Forecasts

BOVESPA:ONCO3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268,218490323N/A8
12/31/20257,343370253N/A10
12/31/20246,433216-553N/A8
9/30/20246,09572-663-422N/A
6/30/20245,862193-614-310N/A
3/31/20245,654211-25662N/A
12/31/20235,489224-363-52N/A
9/30/20235,271219-29285N/A
6/30/20235,033145-24978N/A
3/31/20234,57491-642-346N/A
12/31/20224,08846-572-272N/A
9/30/20223,640-10-740-378N/A
6/30/20223,155105-593-324N/A
3/31/20222,895-67-415-185N/A
12/31/20212,702-47-211-9N/A
9/30/20212,509-203-13827N/A
6/30/20212,354-334-1289N/A
3/31/20212,182-145-17154N/A
12/31/20202,035-158-19186N/A
12/31/20191,690-20-9397N/A
12/31/20181,051-17-296-18N/A
12/31/20177923N/A135N/A
12/31/2016595-25N/A-21N/A
12/31/2015458-25N/A-3N/A
12/31/2014359-22N/A9N/A
12/31/201326921N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ONCO3's forecast earnings growth (47.2% per year) is above the savings rate (10.4%).

Earnings vs Market: ONCO3's earnings (47.2% per year) are forecast to grow faster than the BR market (12.9% per year).

High Growth Earnings: ONCO3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ONCO3's revenue (11.7% per year) is forecast to grow faster than the BR market (7.8% per year).

High Growth Revenue: ONCO3's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ONCO3's Return on Equity is forecast to be low in 3 years time (9.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 08:59
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oncoclínicas do Brasil Serviços Médicos S.A. is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fred MendesBofA Global Research
Flavio YoshidaBofA Global Research
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários